[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:wilms-tumor":3},{"name":4,"total":5,"recruiting":5,"trials":6,"biomarkers":174,"states":179},"Wilms Tumor",27,[7,15,22,29,36,42,48,55,61,67,73,79,85,91,97,103,109,115,121,127,133,139,145,151,156,162,168],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT04968990","Treatment of Newly Diagnosed Patient's With Wilm's Tumor Requiring Abdominal Radiation Delivered With Proton Beam Irradiation",[11],"Phase 2","RECRUITING","2026-08-26T02:18:34.622081Z","2026-05-05T02:43:28.544593Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":20,"content_modified":21},"NCT03810651","Pencil Beam Scanning in Patients With Renal Tumors",[19],"Early Phase 1","2026-08-26T02:18:26.129155Z","2026-05-05T02:43:28.402378Z",{"nct_id":23,"title":24,"phases":25,"status":12,"updated_at":27,"content_modified":28},"NCT06401330","A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)",[26],"Phase 3","2026-08-26T02:16:40.941792Z","2026-05-05T02:43:27.574305Z",{"nct_id":30,"title":31,"phases":32,"status":12,"updated_at":34,"content_modified":35},"NCT07172958","Selective Antigen Specific T Cells and CAR T Cells in Subjects With Relapsed\u002FRefractory Embryonal Tumors (SABRE)",[33],"Phase 1","2026-08-26T02:15:26.669629Z","2026-05-05T02:43:29.230684Z",{"nct_id":37,"title":38,"phases":39,"status":12,"updated_at":40,"content_modified":41},"NCT05985161","A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors",[11],"2026-08-26T02:15:51.395565Z","2026-05-05T02:43:28.556798Z",{"nct_id":43,"title":44,"phases":45,"status":12,"updated_at":46,"content_modified":47},"NCT05521984","Targeting Pediatric Brain Tumors and Relapsed\u002FRefractory Solid Tumors With Sodium Glucose Cotransporter 2 Inhibitors (SGLT2i)",[33],"2026-08-26T02:15:15.642947Z","2026-07-05T05:32:16.804377Z",{"nct_id":49,"title":50,"phases":51,"status":12,"updated_at":53,"content_modified":54},"NCT06625190","Alpha\u002FBeta T and B Cell Depletion With Zoledronic Acid for Solid Tumors",[52],"Phase 1\u002FPhase 2","2026-08-26T02:19:04.543908Z","2026-07-05T03:45:20.453806Z",{"nct_id":56,"title":57,"phases":58,"status":12,"updated_at":59,"content_modified":60},"NCT06198296","Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells",[33],"2026-08-26T02:16:39.977107Z","2026-05-05T02:43:29.711287Z",{"nct_id":62,"title":63,"phases":64,"status":12,"updated_at":65,"content_modified":66},"NCT07148050","Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells",[33],"2026-08-26T02:17:16.126291Z","2026-05-05T02:43:29.698343Z",{"nct_id":68,"title":69,"phases":70,"status":12,"updated_at":71,"content_modified":72},"NCT04851119","Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors",[52],"2026-08-26T02:16:41.943926Z","2026-05-05T02:43:29.139986Z",{"nct_id":74,"title":75,"phases":76,"status":12,"updated_at":77,"content_modified":78},"NCT05135975","A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors",[11],"2026-08-26T02:16:46.147215Z","2026-05-05T02:43:28.530799Z",{"nct_id":80,"title":81,"phases":82,"status":12,"updated_at":83,"content_modified":84},"NCT04308330","Vorinostat in Combination With Chemotherapy in Relapsed\u002FRefractory Solid Tumors and CNS Malignancies",[33],"2026-08-26T02:19:10.436356Z","2026-05-05T02:43:28.511395Z",{"nct_id":86,"title":87,"phases":88,"status":12,"updated_at":89,"content_modified":90},"NCT04897321","B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)",[33],"2026-08-26T02:16:45.157238Z","2026-05-05T02:43:28.511090Z",{"nct_id":92,"title":93,"phases":94,"status":12,"updated_at":95,"content_modified":96},"NCT06500819","Autologous B7-H3 Chimeric Antigen Receptor T Cells in Relapsed\u002FRefractory Solid Tumors",[33],"2026-08-26T02:18:39.640967Z","2026-05-05T02:43:28.289390Z",{"nct_id":98,"title":99,"phases":100,"status":12,"updated_at":101,"content_modified":102},"NCT05238792","Multi Tumor-Associated Antigen-Specific T Lymphocytes to Treat Patients With High Risk Solid Tumors",[33],"2026-08-26T02:19:28.327680Z","2026-05-05T02:43:27.959678Z",{"nct_id":104,"title":105,"phases":106,"status":12,"updated_at":107,"content_modified":108},"NCT04715191","Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors",[33],"2026-08-26T02:16:35.654046Z","2026-05-05T02:43:27.425045Z",{"nct_id":110,"title":111,"phases":112,"status":12,"updated_at":113,"content_modified":114},"NCT04901702","Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma",[52],"2026-08-26T02:18:32.765187Z","2026-05-05T02:35:31.688370Z",{"nct_id":116,"title":117,"phases":118,"status":12,"updated_at":119,"content_modified":120},"NCT05645523","Indocyanine Green (ICG) Guided Sentinel Lymph Node Mapping for Pediatric Visceral Solid Tumors",[19],"2026-08-26T02:17:52.450442Z","2026-05-05T02:43:29.709442Z",{"nct_id":122,"title":123,"phases":124,"status":12,"updated_at":125,"content_modified":126},"NCT04199741","PET\u002FCT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56",[52],"2026-08-26T02:18:04.640417Z","2026-07-05T05:32:16.773657Z",{"nct_id":128,"title":129,"phases":130,"status":12,"updated_at":131,"content_modified":132},"NCT06235125","Safety and Feasibility of Intraoperative Visualization With Cytalux in Children",[33],"2026-08-26T02:16:02.918558Z","2026-05-05T02:43:27.069602Z",{"nct_id":134,"title":135,"phases":136,"status":12,"updated_at":137,"content_modified":138},"NCT04616560","Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor",[52],"2026-08-26T02:17:35.666428Z","2026-07-19T19:36:05.138413Z",{"nct_id":140,"title":141,"phases":142,"status":12,"updated_at":143,"content_modified":144},"NCT06674811","Biomarkers of Resiliency In Childhood Cancer Surgery",[],"2026-08-26T02:19:22.562392Z","2026-05-13T02:55:06.561222Z",{"nct_id":146,"title":147,"phases":148,"status":12,"updated_at":149,"content_modified":150},"NCT07630974","A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D\u002FLIGHTBEAM-U01)",[52],"2026-08-26T02:18:46.137046Z","2026-07-19T19:36:05.145854Z",{"nct_id":152,"title":153,"phases":154,"status":12,"updated_at":131,"content_modified":155},"NCT01247597","DICER1-related Pleuropulmonary Blastoma Cancer Predisposition Syndrome: A Natural History Study",[],"2026-07-05T05:32:16.769834Z",{"nct_id":157,"title":158,"phases":159,"status":12,"updated_at":160,"content_modified":161},"NCT03382158","International PPB\u002FDICER1 Registry",[],"2026-08-26T02:16:22.235886Z","2026-05-13T02:55:06.123104Z",{"nct_id":163,"title":164,"phases":165,"status":12,"updated_at":166,"content_modified":167},"NCT03050268","Familial Investigations of Childhood Cancer Predisposition",[],"2026-08-26T02:17:18.747857Z","2026-05-13T02:55:06.107926Z",{"nct_id":169,"title":170,"phases":171,"status":12,"updated_at":172,"content_modified":173},"NCT01120353","Childhood Cancer Survivor Study",[],"2026-08-26T02:18:27.904411Z","2026-05-13T02:55:06.067987Z",[175],{"biomarker":176,"count":177,"slug":178},"Glypican-3",3,"glypican-3",[180,184,187,190,193,197,200,203,206,210,213,216,219,222,226,230,233,236,239,242,245],{"state":181,"count":182,"slug":183},"District of Columbia",9,"district-of-columbia",{"state":185,"count":182,"slug":186},"New York","new-york",{"state":188,"count":182,"slug":189},"Tennessee","tennessee",{"state":191,"count":182,"slug":192},"Texas","texas",{"state":194,"count":195,"slug":196},"California",7,"california",{"state":198,"count":195,"slug":199},"Illinois","illinois",{"state":201,"count":195,"slug":202},"Minnesota","minnesota",{"state":204,"count":195,"slug":205},"Pennsylvania","pennsylvania",{"state":207,"count":208,"slug":209},"Colorado",6,"colorado",{"state":211,"count":208,"slug":212},"Georgia","georgia",{"state":214,"count":208,"slug":215},"Massachusetts","massachusetts",{"state":217,"count":208,"slug":218},"Missouri","missouri",{"state":220,"count":208,"slug":221},"Ohio","ohio",{"state":223,"count":224,"slug":225},"Alabama",5,"alabama",{"state":227,"count":228,"slug":229},"Indiana",4,"indiana",{"state":231,"count":228,"slug":232},"Michigan","michigan",{"state":234,"count":228,"slug":235},"Utah","utah",{"state":237,"count":228,"slug":238},"Washington","washington",{"state":240,"count":177,"slug":241},"Florida","florida",{"state":243,"count":177,"slug":244},"Maryland","maryland",{"state":246,"count":177,"slug":247},"New Jersey","new-jersey"]